Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

General Organization for Teaching Hospitals and Institutes

Status: Completed

Conditions: Childhood Pneumonia

Treatments: Dietary Supplement: Oral Rehydration Solution

Study type: Interventional

Funder types: Other

Identifiers

NCT06951347

HM000174

Details and patient eligibility

About

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia.

It aims to answer:

• Does sodium supplementation lower the length of hospital stay in children with pneumonia?
• Does potassium supplementation lower the length of hospital stay in children with pneumonia?

Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay.

Participants will:

• Take one sachet of oral rehydration solution (ORS) every day for 3 days.

Full description

The study is a randomized clinical trial that will be conducted on hospitalized children with pneumonia after considering exclusion criteria.

The enrolled children will be randomly divided into two groups: the intervention group and the control group. The intervention group will receive the ORS daily for 3 days.

All children will be followed until discharge from the hospital, and their clinical outcomes will be assessed.

Enrollment: 140 patients

Sex: All

Ages: 1 month to 5 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Infants and children aged between 1 month and 5 years.
• Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.

Exclusion criteria

• Children with other comorbidities.
• Those whose parents will show disapproval for the participation of the study.
• Children on medications that affect sodium and potassium levels.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

140 participants in 2 patient groups

Intervention Group

Experimental group

Treatment:

Dietary Supplement: Oral Rehydration Solution

Control Group

No Intervention group